NYSE:RFL Rafael Q4 2026 Earnings Results & Report $1.18 -0.03 (-2.40%) As of 10:41 AM Eastern This is a fair market value price provided by Massive. Learn more. Rafael reported Q4 2026 earnings on October 29, 2026. The company reported EPS of -$0.18, while revenue was $244 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2026Report DateOctober 29, 2026TimeBefore Market OpensConference Call9:30 AM ET Rafael EPS ResultsActual EPS-$0.18Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ARafael Revenue ResultsActual Revenue$244 thousandExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K) Rafael Q4 2026 Earnings FAQ Did Rafael beat earnings estimates for Q4 2026? Rafael (NYSE:RFL) reported earnings of -$0.18 per share for Q4 2026. The report was announced on Thursday, October 29, 2026. What was Rafael's revenue for Q4 2026? Rafael reported revenue of $244 thousand for Q4 2026. Rafael Earnings HeadlinesRafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update2 hours ago | globenewswire.comRafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C3 hours ago | globenewswire.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.October 29 at 1:00 AM | Behind the Markets (Ad)Rafael (RFL) versus Its Competitors Head to Head AnalysisOctober 28 at 4:15 AM | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Rafael Holdings, Inc. - RFLOctober 27 at 6:42 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFLOctober 22, 2026 | prnewswire.comSee More Rafael Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Rafael? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rafael and other key companies, straight to your email. Email Address About RafaelRafael (NYSE:RFL) (NYSE:RFL) is a diversified holding company with interests in biotechnology and commercial real estate. Through its life sciences operations, the company has focused on developing potential treatments for cancer and other serious diseases, including therapies designed to target the metabolism of cancer cells. Rafael’s biotechnology activities have been conducted primarily through Rafael Pharmaceuticals, which has researched investigational drug candidates such as devimistat (also known as CPI-613). The company’s pharmaceutical programs are subject to clinical, regulatory and commercial uncertainties, and products under development may not receive regulatory approval. The company also owns and manages commercial real estate assets, with a significant portion of its real estate interests located in Israel. Rafael Holdings was formed through the separation of certain businesses from IDT Corporation. Howard S. Jonas, the founder of IDT Corporation, has been closely associated with Rafael Holdings’ leadership and strategic direction.View Rafael ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps GrowingEnphase Energy's Solar Slump Raises a Question About Its AI Data Center AmbitionsHeavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure WinnerGarmin Raises Its Profit Outlook—Can the Stock Reach New Highs?The Invisible AI Backbone: Corning's AI Fiber PlayWhy Tesla’s Upside Is About More Than a SpaceX MergerBoeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check Upcoming Earnings Colgate-Palmolive (10/30/2026)BP (10/30/2026)Chevron (10/30/2026)ExxonMobil (10/30/2026)NatWest Group (10/30/2026)AbbVie (10/30/2026)AstraZeneca (10/30/2026)Regeneron Pharmaceuticals (10/30/2026)Sanofi (10/30/2026)Canadian National Railway (10/30/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
